BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ding L, Xu WJ, Tao XY, Zhang L, Cai ZG. Clinicopathological features of superficial CD34-positive fibroblastic tumor. World J Clin Cases 2021; 9(12): 2739-2750 [PMID: 33969057 DOI: 10.12998/wjcc.v9.i12.2739]
URL: https://www.wjgnet.com/2307-8960/full/v9/i12/2739.htm
Number Citing Articles
1
Haneen T. Salah, Julieta A. D'Ardis, Donghwa Baek, Juanita Duran, Mary R. Schwartz, Alberto G. Ayala, Jae Y. Ro. Case of recurrent superficial CD34‐positive fibroblastic tumorJournal of Cutaneous Pathology 2023; 50(6): 477 doi: 10.1111/cup.14329
2
Haneen T. Salah, Julieta A. D'ardis, Donghwa Baek, Mary R. Schwartz, Alberto G. Ayala, Jae Y. Ro. Superficial CD34-positive fibroblastic tumor (SCPFT): A review of pathological and clinical featuresAnnals of Diagnostic Pathology 2022; 58: 151937 doi: 10.1016/j.anndiagpath.2022.151937
3
Bruce M. Wenig, Juan C. Hernandez-Prera. Atlas of Head and Neck Pathology2023; : 673 doi: 10.1016/B978-0-323-71257-6.00013-7
4
Juan Sun, Shengliang Huang, Xiaoqing Yang. Superficial CD34+ fibroblastic tumor with focal atypical presentation: A case reportOncology Letters 2024; 28(1) doi: 10.3892/ol.2024.14468
5
Raul Perret, Isabelle Hostein. Superficial CD34-Positive Fibroblastic TumorSurgical Pathology Clinics 2024; 17(1): 1 doi: 10.1016/j.path.2023.06.001
6
Olisaemeka Chukwudebe, Ryanne A. Brown. Immunohistochemical and molecular updates in cutaneous soft tissue neoplasmsSeminars in Diagnostic Pathology 2022; 39(4): 257 doi: 10.1053/j.semdp.2022.02.004